Strategic partnerships VivoSense has recent high-profile collaborations with Otsuka Group and Cambridge Cognition, signaling openness to co-developing digital health solutions and expanding in pharma and cognitive/neurological spaces. This presents a sales opportunity to position joint development or integration services for large pharma & CRO partnerships.

Clinical evidence leadership The company actively publishes and contributes to digital sleep, Alzheimer's, and neurodegenerative research, underscoring credibility in patient-centric digital endpoints. Leverage these practices to propose expanded endpoints, real-world data programs, or validation studies for sponsors seeking robust digital biomarkers.

Wearable data expertise As a dedicated wearable sensor CRO with end-to-end data handling and a proprietary DHT platform, VivoSense offers turnkey data workflows, from device vetting to analysis. Position as a one-stop solution for sponsors needing scalable, compliant sensor data pipelines for large trials.

Global execution read The company highlights decades of digital health implementation experience and a diverse tech stack in cloud and analytics, suggesting readiness for multicenter, multinational trials. Opportunity to upsell enterprise-grade data security, auditable workflows, and regulatory-compliant data management services.

Growth signals Revenue in the mid-range and a growing publication footprint imply momentum and potential for expansion into additional disease areas or larger-scale studies. Target opportunities for long-term CRO relationships, expanded study scopes, and multi-year collaborations.